We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · April 23, 2020

Efficacy of Eribulin Mesylate in Older Patients With Breast Cancer

Journal of Geriatric Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Geriatric Oncology
Efficacy of Eribulin Mesylate in Older Patients With Breast Cancer: A Pooled Analysis of Clinical Trial and Real-World Data
J Geriatr Oncol 2020 Apr 13;[EPub Ahead of Print], R Pedersini, P di Mauro, V Amoroso, MC Parati, A Turla, M Ghilardi, L Vassalli, M Ardine, AD Volta, S Monteverdi, K Borgonovo, A Ghidini, M Cabiddu, EL Simoncini, F Petrelli, A Berruti, S Barni

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading